Pfizer CEO Bourla to meet with activist investor Starboard Value on turnaround pitch: FT
With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the company’s executives will reportedly hear out activist investor Starboard Valu | Activist investor Starboard Value recently picked up a $1 billion stake in the drugmaker and will now pitch a strategy shift to top executives,
Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback